Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Pharmacy World & Science : PWS|December 13, 2005
Side effects of interferon-alpha therapyStefan Sleijfer, Marjolein Bannink, Arthur R Van Gool, et al.
Palliative Medicine|July 21, 2007
Changes in and correlates of individual quality of life in advanced cancer patients admitted to an academic unit for palliative careMichael A Echteld, Lia van Zuylen, Marjolein Bannink, et al.
Pharmacy World & Science : PWS|March 29, 2003
Neuropsychiatric side effects of interferon-alfa therapyArthur R Van Gool, Wim H J Kruit, Frederike K Engels, et al.
Breast Cancer Research and Treatment|June 14, 2013
Unjustified prescribing of CYP2D6 inhibiting SSRIs in women treated with tamoxifenLisette Binkhorst, Ron H J Mathijssen, Myrthe P P van Herk-Sukel, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 22, 2004
Platelet MAO activity during treatment with pegylated interferon-alfa in melanoma patientsMarjolein Bannink, Wim H J Kruit, Arthur R Van Gool, et al.
Psychosomatics|January 24, 2008
Interferon-alpha in oncology patients: fewer psychiatric side effects than anticipatedMarjolein Bannink, Wim H J Kruit, Arthur R Van Gool, et al.
Psychiatry Research|July 16, 2003
Serum amino acids, biopterin and neopterin during long-term immunotherapy with interferon-alpha in high-risk melanoma patientsArthur R Van Gool, Durk Fekkes, Wim H J Kruit, et al.
Neuropsychobiology|September 18, 2007
Interferon-alpha influences tryptophan metabolism without inducing psychiatric side effectsMarjolein Bannink, Durk Fekkes, Arthur R Van Gool, et al.
Amino Acids|October 28, 2008
Nitric oxide production and monoamine oxidase activity in cancer patients during interferon-alpha therapyDurk Fekkes, Arthur R Van Gool, Marjolein Bannink, et al.
Pageof 2